Health

Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies

Supports Development of Phospholipid Radioconjugate (PRC) CLR-225 for the Treatment of Solid Tumors December 16, 2025 08:05 ET  | Source:…

4 weeks ago

Synergy CHC Corp. (NASDAQ: SNYR) Appoints Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America

Role Supports Synergy’s Expanding Presence in Mexico, Including Initial Product Shipments to Costco Mexico December 16, 2025 08:00 ET  |…

4 weeks ago

Starton Therapeutics to Present at Biotech Showcase 2026

Company Will Also Host 1x1 Investor Meetings at the 15th Annual LifeSci Partners Corporate Access Event from January 13-14th in…

4 weeks ago

Face-Art Maestro Dr Jaffer Khan Pioneers Aesthetic Artistry for Advanced Plastic Surgery in Dubai

DUBAI, United Arab Emirates, Dec. 15, 2025 (GLOBE NEWSWIRE) -- In Dubai, Dr. Jaffer Khan is redefining plastic surgery, elevating…

4 weeks ago

Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and Pancreatic Cancer

AGOURA HILLS, Calif., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) in collaboration with the Brush and Key…

4 weeks ago

Trinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances

December 15, 2025 09:15 ET  | Source: Trinity Biotech plc Company advances its mission to deliver next-generation diabetes management solutions…

4 weeks ago

Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods

BRISBANE, Australia and CAMBRIDGE, Mass., Dec. 14, 2025 (GLOBE NEWSWIRE) -- Australian biotechnology pioneer Vaxxas Pty Ltd, has been granted…

4 weeks ago

InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial

BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the…

4 weeks ago

Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026

December 12, 2025 16:30 ET  | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) --…

4 weeks ago

Extendicare Announces December 2025 Dividend of C$0.042 per Share

December 12, 2025 17:00 ET  | Source: Extendicare Inc. MARKHAM, Ontario, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare”…

4 weeks ago